A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage

Johnson & Johnson (J&J)

Status: Completed

Conditions: Hypersensitivity; Common Cold; Sinusitis

Study type: Observational

Funder types: Industry

Identifiers

NCT05126407

CCSURA003229 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to proactively collect customer feedback on the performance aspects and risk factors of Olynth Nasal Saline Drops/Spray and Olynth Ectomed Nasal Spray.

Enrollment: 87 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Aged 18 years or older who has personally used or administered the nasal drops/spray to a child
• Has personally used or administered to a child, the Nasal Drops/Spray at least once within the past 6 months
• Able to read, write, speak, and understand German
• Has internet access to complete an on-line survey
• Intends to complete the survey
• Individual has signed the informed consent document (ICD)

Exclusion criteria

• Is an employee/contractor or immediate family member of the principal investigator (PI), Schlesinger group, product perceptions limited (PPL) Insights or sponsor of this study

Trial design

87 participants in 1 patient group

Olynth Nasal Saline Drops/Spray and Olynth Ectomed Nasal Spray

Description:

Participants who have personally used or administered the Olynth Nasal Saline Drops/Spray and Olynth Ectomed Nasal Spray to a child at least once within the past 6 months will provide feedback via electronic survey on the prior use of the Drop/Spray.